Emergent BioSolutions Inc. — Director's Dealing 2016

Aug 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2016-07-29

Reporting Person: Emergent BioSolutions Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-29	Common Stock, par value $0.001 per share	J	20229074	$0.00	Acquired	20230074	Direct
2016-08-01	Common Stock, par value of $0.001 per share	J	20230074	$0.00	Disposed	0	Direct

Footnotes

F1: On July 29, 2016, Aptevo Therapuetics, Inc. ("Aptevo") issued 20,229,074 shares of its common stock to its parent, Emergent Biosolutions Inc ("Emergent"), as partial consideration for Emergent's transfer of its biosciences business to Aptevo.

F2: On August 1, 2016, Emergent made a pro rata distribution of 100% of the outstanding shares of Aptevo common stock to Emergent stockholders of record as of July 22, 2016, the record date for the distribution.